Analytical Data
-
Gene name
BMPRIB/ALK-6
- Application
-
Biological Activity
Measured by its ability to inhibit rhBMP-4-induced alkaline phosphatase production by ATDC5 mouse chondrogenic cells. The ED50 for this effect is 0.1346 µg/mL in the presence of 30 ng/mL of rhBMP-4. Corresponding to a specific activity is 7.429×103 U/mg. Measured by its ability to inhibit rhBMP-4-induced alkaline phosphatase production by ATDC5 mouse chondrogenic cells. The ED50 for this effect is 0.1346 µg/mL in the presence of 30 ng/mL of rhBMP-4.corresponding to a specific activity is 7.429×103 U/mg.
-
Alternative Names
Bone morphogenetic protein receptor type-1B; BMPR-1B; CDw293
-
Species
Mouse
-
Source
HEK293
-
Tag
C-hFc
-
Purity
Greater than 95% as determined by reducing SDS-PAGE.
-
Uniprot
P36898
-
Expression Region
K14-K126
-
Protein Length
Extracellular Domain
-
Molecular Weight
39.4 kDa.
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Bone morphogenetic protein receptor type IB (BMPRIB), also known as activin-like kinase 6 (ALK-6), is a member of the transforming growth factor-beta (TGF-β) superfamily, playing a crucial role in various biological processes such as embryonic development, tissue homeostasis, and cellular differentiation. Studies on BMPRIB/ALK-6 have gained significant attention due to its implications in bone formation, cardiovascular development, and the regulation of cellular signaling pathways, particularly the SMAD-dependent and non-SMAD pathways. Dysregulation of BMPRIB/ALK-6 signaling has been linked to several diseases, including pulmonary arterial hypertension and various forms of cancer, making it a potential therapeutic target. Recent research efforts focus on elucidating the structural and functional aspects of this receptor, its binding affinities with ligands, and how it interacts with other cellular components. Understanding the mechanisms by which BMPRIB/ALK-6 regulates cellular processes may open new avenues for innovative treatment strategies in regenerative medicine and oncology, emphasizing the need for continued investigation into its biological significance and potential clinical applications.











